The etiology and pathophysiological mechanisms of idiopathic pulmonary fibrosis (IPF) are yet to be fully elucidated; however, mining of diseaserelated microRNAs (miRNAs/miRs) has improved the understanding of the progression of IPF. The aim of the current study was to screen miRNAs
associated with IPF using three mathematical algorithms: Oneway ANOVA, least absolute shrinkage and selector operation (LASSO) and support vector machinerecursive feature elimination (SVMRFE). Using ANOVA, three miRNAs and two miRNAs were selected with opposite expression patterns in
moderate and severe IPF, respectively. In total, two algorithms, LASSO and SVMRFE, were used to perform feature selection of miRNAs. miRNAs from patients were also extracted from formalinfixed paraffinembedded tissues and detected using reverse transcriptionquantitative PCR (RTqPCR). The intersection
of the three algorithms (ANOVA, LASSO and SVMRFE) was taken as the final result of the miRNA candidates. Three miRNA candidates, including miR124, hsamiR5245p and hsamiR194 were therefore used as biomarkers. The receiver operating characteristic model demonstrated favorable discrimination
between IPF and control groups, with an area under the curve of 78.5%. Moreover, RTqPCR results indicated that miR124, hsamiR5245p, hsamiR194 and hsamiR133a were differentially expressed between patients with IPF and agematched men without fibrotic lung disease. The target genes of these miRNAs
were further predicted and Kyoto Encyclopedia of Genes and Genomes enrichment analysis was performed. Collectively, the present results suggested that the identified miRNAs associated with IPF may be useful biomarkers for the diagnosis of this disease.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
College of Bioscience and Biotechnology, Shenyang Agricultural University, Shenyang, Liaoning 110866, P.R. China
College of Food Science, Shenyang Agricultural University, Shenyang, Liaoning 110866, P.R. China
Department of Pharmacy, Fushun Central Hospital, Fushun, Liaoning 113006, P.R. China
Department of Pathology, Shenyang Thoracic Hospital, Shenyang, Liaoning 110044, P.R. China
October 1, 2020
More about this publication?
Experimental and Therapeutic Medicine aims to ensure the expedient publication, in both print and electronic format, of studies relating to biology, gene therapy, infectious disease, microbiology, molecular cardiology and molecular surgery. The journal welcomes studies pertaining to all aspects of molecular medicine, and studies relating to in vitro or in vivo experimental model systems relevant to the mechanisms of disease are also included.
All materials submitted to this journal undergo the appropriate review via referees who are experts in this field. All materials submitted follow international guidelines with regard to approval of experiments on humans and animals.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites